MCM
CLBT icon

MAI Capital Management’s Cellebrite CLBT Stock Holding History

MAI Capital Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.57K Buy
+622
New +$9.37K ﹤0.01% 3240
2025
Q4 		– Sell
-76
Closed -$1.41K – 4378
2025
Q3 		$1.41K Buy
+76
New +$1.19K ﹤0.01% 3398

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MAI Capital Management's CLBT Position: Q1 2026 in Review

MAI Capital Management opened a new position in Cellebrite (CLBT) in Q1 2026: 622 shares worth $8.57K. The stake represents ﹤0.01% of the portfolio and ranks #3240 among its holdings. This is a return to the name: MAI Capital Management previously reported a position in CLBT as recently as Q3 2025.

MAI Capital Management first reported a position in CLBT in Q3 2025 and has held it in 2 quarters since. 220 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • MAI Capital Management held 622 shares of Cellebrite worth $8.57K as of Q1 2026.
  • Cellebrite was a new MAI Capital Management position in Q1 2026.
  • Cellebrite made up ﹤0.01% of MAI Capital Management's portfolio in Q1 2026, its #3240 holding.
  • MAI Capital Management first reported a position in Cellebrite in Q3 2025 and has held it in 2 quarters since.
  • 220 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.